PTM BIO

PTM BIO is a specialized tools and services company operating in the high-growth proteomics and epigenetics research market. It has built a diversified business model offering contract research services (proteomics, bioinformatics, drug R&D), a wide array of research-grade antibody reagents, and a line of in-vitro diagnostic (IVD) products. While privately held and likely in an early-revenue stage, the company demonstrates a clear focus on the critical but complex area of protein post-translational modifications, serving academic, biopharma, and diagnostic labs globally.

Mass spectrometry-based proteomics platform specializing in post-translational modification (PTM) analysis, including 4D proteomics and single-cell proteomics. Coupled with a bioinformatics suite (PTM Cloud) for data analysis and a proprietary antibody development platform for PTM-specific research reagents.

PTM BIO competes in the crowded proteomics services and research antibodies market against giants like Thermo Fisher Scientific, Abcam, and Bio-Techne, as well as specialized proteomics CROs. Its differentiation hinges on deep specialization in PTM analysis and a vertically integrated model offering services, software, and reagents for this niche.